— last modified 24 October 2023 The European Commission adopted on 24 October a set of actions to better prevent and mitigate critical medicine shortages in the EU, this winter,…
— last modified 09 July 2009 The European Commission is an active member of the World Health Organisations International Medical Products Task Force (IMPACT). IMPACT counts all the major anti-counterfeiting…
— last modified 09 July 2009 Research and development (R&D) in life sciences is a precondition to pharmaceutical innovation. The Commission recognises the key role pharmaceutical R&D plays. Consequently, it…
— last modified 09 July 2009 The EU Transparency Directive lays down harmonised provisions to ensure the transparency of measures adopted by national authorities to regulate the pricing and reimbursement…
— last modified 11 December 2008 Medicinal products contribute considerably to the health of EU citizens. They can, however, also have adverse effects. It is estimated that 5% of all…
— last modified 11 December 2008 Citizens of the European Union have become more empowered and proactive consumers of healthcare, increasingly seeking information about medicines and treatments. EU citizens want…
— last modified 11 December 2008 The European Commission has proposed today to protect the legal distribution chain from the infiltration of fake medicines. This is aimed at helping to…
